Overview

Alltera (Lopinavir 200 mg + Ritonavir 50 mg) Tablets is an antiretroviral medication belonging to the class of protease inhibitors. It is formulated as a fixed-dose combination to improve adherence and efficacy in HIV treatment.

Key Benefits

• Controls HIV viral replication and reduces viral load
• Boosts immune system function and CD4 counts
• Improves adherence by combining two drugs in one tablet

How It Works

Lopinavir inhibits HIV-1 protease, preventing cleavage of viral polyproteins into functional proteins. Ritonavir acts as a pharmacokinetic enhancer, increasing lopinavir plasma concentration by inhibiting CYP3A metabolism.

Dosage & Administration

Recommended dose: 2 tablets (200/50 mg) twice daily with food, or as directed by a healthcare provider. Pediatric dosing is weight-based.

Safety & Precautions

• Common side effects: diarrhea, nausea, abdominal pain, elevated lipids
• Use with caution in patients with liver disease or pancreatitis
• Potential for multiple drug–drug interactions; consult healthcare provider

Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Patients must consult a licensed physician before initiating ART.